
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $23.3B | $42.1B | $57.3B | $48.7B | $50.1B | |
Revenue Growth (YoY) | -30.83% | 80.67% | 36.28% | -15.05% | 2.79% | |
Cost of Revenues | $21.1B | $39.3B | $54.1B | $45.6B | $46.6B | |
Gross Profit | $2.2B | $2.8B | $3.2B | $3.1B | $3.5B | |
Gross Profit Margin | 9.46% | 6.65% | 5.58% | 6.43% | 6.96% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $276M | $298M | $330M | $356M | $387M | |
Other Inc / (Exp) | -$3B | -$297M | $261M | $624M | $302M | |
Operating Expenses | $1.4B | $1.4B | $1.6B | $1.8B | $2.2B | |
Operating Income | $851M | $1.4B | $1.6B | $1.3B | $1.3B | |
Net Interest Expenses | $436M | $425M | $405M | $359M | $360M | |
EBT. Incl. Unusual Items | -$2.6B | $712M | $1.4B | $1.6B | $1.3B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$167M | $112M | $246M | $189M | $204M | |
Net Income to Company | -$2.4B | $600M | $1.2B | $1.4B | $1.1B | |
Minority Interest in Earnings | $1.9B | -$540M | -$995M | -$1.2B | -$967M | |
Net Income to Common Excl Extra Items | -$568M | $60M | $168M | $198M | $103M | |
Basic EPS (Cont. Ops) | -$3.06 | $0.31 | $0.86 | $1.01 | $0.52 | |
Diluted EPS (Cont. Ops) | -$3.07 | $0.31 | $0.86 | $1.01 | $0.52 | |
Weighted Average Basic Share | $186M | $194M | $194M | $195M | $197M | |
Weighted Average Diluted Share | $246M | $194M | $194M | $195M | $197M | |
EBITDA | -$1.5B | $1.9B | $2.8B | $3.1B | $2.7B | |
EBIT | -$2.2B | $1.1B | $1.8B | $2B | $1.7B | |
Revenue (Reported) | $23.3B | $42.1B | $57.3B | $48.7B | $50.1B | |
Operating Income (Reported) | $851M | $1.4B | $1.6B | $1.3B | $1.3B | |
Operating Income (Adjusted) | -$2.2B | $1.1B | $1.8B | $2B | $1.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Revenue Growth (YoY) | 1.38% | 63.35% | -9.88% | -2.8% | 0.13% | |
Cost of Revenues | $7.6B | $13B | $11.6B | $11.2B | $11B | |
Gross Profit | $813M | $678M | $761M | $824M | $988M | |
Gross Profit Margin | 9.7% | 4.95% | 6.17% | 6.87% | 8.23% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $68M | $83M | $87M | $97M | $101M | |
Other Inc / (Exp) | $26M | $102M | $307M | $85M | $148M | |
Operating Expenses | $287M | $429M | $444M | $455M | $469M | |
Operating Income | $526M | $249M | $317M | $369M | $519M | |
Net Interest Expenses | $107M | $107M | $98M | $90M | $102M | |
EBT. Incl. Unusual Items | $445M | $244M | $526M | $364M | $565M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53M | $35M | $83M | $28M | $73M | |
Net Income to Company | $392M | $209M | $443M | $336M | $492M | |
Minority Interest in Earnings | -$322M | -$187M | -$374M | -$294M | -$408M | |
Net Income to Common Excl Extra Items | $70M | $22M | $69M | $42M | $84M | |
Basic EPS (Cont. Ops) | $0.36 | $0.11 | $0.35 | $0.21 | $0.42 | |
Diluted EPS (Cont. Ops) | $0.36 | $0.11 | $0.35 | $0.21 | $0.42 | |
Weighted Average Basic Share | $194M | $194M | $194M | $197M | $198M | |
Weighted Average Diluted Share | $194M | $194M | $194M | $197M | $198M | |
EBITDA | $730M | $582M | $881M | $713M | $934M | |
EBIT | $552M | $351M | $624M | $459M | $672M | |
Revenue (Reported) | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Operating Income (Reported) | $526M | $249M | $317M | $369M | $519M | |
Operating Income (Adjusted) | $552M | $351M | $624M | $459M | $672M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $23.4B | $47.4B | $56B | $48.4B | $50.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $21.1B | $44.7B | $52.7B | $45.2B | $46.4B | |
Gross Profit | $2.3B | $2.7B | $3.3B | $3.2B | $3.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $274M | $314M | $334M | $365M | $390M | |
Other Inc / (Exp) | $81M | -$220M | $465M | $408M | $363M | |
Operating Expenses | $1.3B | $1.5B | $1.7B | $1.8B | $2.2B | |
Operating Income | $1B | $1.2B | $1.6B | $1.4B | $1.5B | |
Net Interest Expenses | $435M | $426M | $396M | $357M | $373M | |
EBT. Incl. Unusual Items | $664M | $510M | $1.7B | $1.5B | $1.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $19M | $93M | $293M | $134M | $249M | |
Net Income to Company | $644M | $417M | $1.4B | $1.3B | $1.2B | |
Minority Interest in Earnings | -$562M | -$404M | -$1.2B | -$1.1B | -$1.1B | |
Net Income to Common Excl Extra Items | $83M | $13M | $215M | $171M | $145M | |
Basic EPS (Cont. Ops) | $0.43 | $0.07 | $1.10 | $0.87 | $0.75 | |
Diluted EPS (Cont. Ops) | $0.43 | $0.07 | $1.10 | $0.87 | $0.75 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.8B | $1.8B | $3.1B | $2.9B | $2.9B | |
EBIT | $1.1B | $936M | $2.1B | $1.8B | $1.9B | |
Revenue (Reported) | $23.4B | $47.4B | $56B | $48.4B | $50.1B | |
Operating Income (Reported) | $1B | $1.2B | $1.6B | $1.4B | $1.5B | |
Operating Income (Adjusted) | $1.1B | $936M | $2.1B | $1.8B | $1.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $7.6B | $13B | $11.6B | $11.2B | $11B | |
Gross Profit | $813M | $678M | $761M | $824M | $988M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $68M | $83M | $87M | $97M | $101M | |
Other Inc / (Exp) | $26M | $102M | $307M | $85M | $148M | |
Operating Expenses | $287M | $429M | $444M | $455M | $469M | |
Operating Income | $526M | $249M | $317M | $369M | $519M | |
Net Interest Expenses | $107M | $107M | $98M | $90M | $102M | |
EBT. Incl. Unusual Items | $445M | $244M | $526M | $364M | $565M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53M | $35M | $83M | $28M | $73M | |
Net Income to Company | $392M | $209M | $443M | $336M | $492M | |
Minority Interest in Earnings | -$322M | -$187M | -$374M | -$294M | -$408M | |
Net Income to Common Excl Extra Items | $70M | $22M | $69M | $42M | $84M | |
Basic EPS (Cont. Ops) | $0.36 | $0.11 | $0.35 | $0.21 | $0.42 | |
Diluted EPS (Cont. Ops) | $0.36 | $0.11 | $0.35 | $0.21 | $0.42 | |
Weighted Average Basic Share | $194M | $194M | $194M | $197M | $198M | |
Weighted Average Diluted Share | $194M | $194M | $194M | $197M | $198M | |
EBITDA | $730M | $582M | $881M | $713M | $934M | |
EBIT | $552M | $351M | $624M | $459M | $672M | |
Revenue (Reported) | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Operating Income (Reported) | $526M | $249M | $317M | $369M | $519M | |
Operating Income (Adjusted) | $552M | $351M | $624M | $459M | $672M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $25M | $452M | $404M | $453M | $349M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $2.6B | $4.7B | $3.9B | $3.8B | $3.9B | |
Inventory | $647M | $783M | $729M | $548M | $439M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $405M | $200M | $318M | $155M | $87M | |
Total Current Assets | $3.7B | $6.1B | $5.4B | $4.9B | $4.8B | |
Property Plant And Equipment | $15B | $15.3B | $15.6B | $16.1B | $15.8B | |
Long-Term Investments | $3.8B | $3.8B | $3.1B | $2.8B | $2.8B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $805M | $2B | $2.1B | $1.9B | $1.7B | |
Other Long-Term Assets | $1.3B | $1.4B | $1.7B | $1.7B | $1.5B | |
Total Assets | $26B | $30B | $29.2B | $28.6B | $27.8B | |
Accounts Payable | $2.4B | $4.8B | $4B | $3.8B | $3.9B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $117M | $72M | $59M | $13M | $15M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $999M | $601M | $689M | $714M | $635M | |
Total Current Liabilities | $4.3B | $6.2B | $5.9B | $5B | $4.9B | |
Long-Term Debt | $9.4B | $8.4B | $7.3B | $7.3B | $7.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $14.8B | $15.8B | $14.6B | $13.6B | $13.4B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $1.5B | $1.5B | $1.5B | $1.5B | $1.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $9.7B | $12.6B | $13.1B | $13.4B | $13B | |
Total Equity | $11.2B | $14.2B | $14.6B | $15B | $14.3B | |
Total Liabilities and Equity | $26B | $30B | $29.2B | $28.6B | $27.8B | |
Cash and Short Terms | $25M | $452M | $404M | $453M | $349M | |
Total Debt | $10.2B | $9.2B | $8.4B | $7.8B | $7.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $32M | $117M | $529M | $334M | $429M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.4B | $7.1B | $4B | $4B | $3.8B | |
Inventory | $484M | $527M | $463M | $453M | $335M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $483M | $320M | $165M | $177M | $145M | |
Total Current Assets | $4.4B | $8.1B | $5.1B | $5B | $4.7B | |
Property Plant And Equipment | $15B | $15.3B | $15.5B | $16B | $16.4B | |
Long-Term Investments | $3.8B | $3.8B | $3.1B | $2.9B | $2.7B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | $2.1B | -- | $1.7B | |
Other Long-Term Assets | $2.2B | $1.6B | $1.6B | $1.7B | $1.5B | |
Total Assets | $26.7B | $32B | $28.7B | $28.6B | $28.3B | |
Accounts Payable | $3.4B | $6.9B | $4B | $4B | $3.7B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $117M | $518M | $708M | $14M | $14M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1B | $801M | $650M | $600M | $481M | |
Total Current Liabilities | $4.7B | $8.6B | $5.4B | $5.1B | $4.7B | |
Long-Term Debt | $9.3B | $8B | $7.3B | $7.3B | $8.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $15.2B | $17.8B | $14B | $13.7B | $14.2B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -$333M | |
Minority Interest, Total | $10B | $12.7B | $13.2B | $13.4B | $12.7B | |
Total Equity | $11.5B | $14.2B | $14.8B | $14.9B | $14.1B | |
Total Liabilities and Equity | $26.7B | $32B | $28.7B | $28.6B | $28.3B | |
Cash and Short Terms | $32M | $117M | $529M | $334M | $429M | |
Total Debt | $9.6B | $8.9B | $8B | $7.9B | $8.7B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.4B | $600M | $1.2B | $1.4B | $1.1B | |
Depreciation & Amoritzation | $656M | $777M | $968M | $1.1B | $1B | |
Stock-Based Compensation | $16M | $24M | $41M | $51M | $52M | |
Change in Accounts Receivable | $1.4B | -$2.2B | $649M | $213M | $112M | |
Change in Inventories | -$304M | -$18M | -$10M | $223M | $70M | |
Cash From Operations | $1.5B | $2B | $2.4B | $2.7B | $2.5B | |
Capital Expenditures | $738M | $336M | $539M | $582M | $640M | |
Cash Acquisitions | -$771M | -$126M | -$163M | -$458M | -$252M | |
Cash From Investing | -$1.1B | $386M | -$526M | -$702M | -$875M | |
Dividends Paid (Ex Special Dividend) | -$166M | -$140M | -$162M | -$209M | -$251M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.2B | -- | -- | $433M | $650M | |
Long-Term Debt Repaid | -$777M | -$912M | -$750M | -$1.1B | -$790M | |
Repurchase of Common Stock | -$50M | -$178M | -$74M | -- | -- | |
Other Financing Activities | -$641M | -$749M | -$941M | -$1.1B | -$1.3B | |
Cash From Financing | -$430M | -$2B | -$1.9B | -$2B | -$1.7B | |
Beginning Cash (CF) | $84M | $63M | $456M | $404M | $453M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$13M | $398M | -$49M | $49M | -$93M | |
Ending Cash (CF) | $63M | $456M | $404M | $453M | $349M | |
Levered Free Cash Flow | $772M | $1.7B | $1.9B | $2.1B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $392M | $209M | $443M | $336M | $492M | |
Depreciation & Amoritzation | $178M | $231M | $257M | $254M | $262M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $789M | $339M | $742M | $418M | $638M | |
Capital Expenditures | $97M | $101M | $122M | $170M | $198M | |
Cash Acquisitions | -$35M | -$3M | -$4M | -$94M | -$624M | |
Cash From Investing | -$108M | -$81M | $158M | -$261M | -$819M | |
Dividends Paid (Ex Special Dividend) | -$35M | -$35M | -$52M | -$63M | -$75M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $382M | -- | $107M | $1.1B | |
Long-Term Debt Repaid | -$576M | -$750M | -$400M | -- | -- | |
Repurchase of Common Stock | -$3M | -$25M | -- | -- | -$333M | |
Other Financing Activities | -$72M | -$168M | -$323M | -$316M | -$399M | |
Cash From Financing | -$686M | -$596M | -$775M | -$272M | $262M | |
Beginning Cash (CF) | $63M | $456M | $404M | $453M | $349M | |
Foreign Exchange Rate Adjustment | -- | $3M | -- | -$4M | -$1M | |
Additions / Reductions | -$5M | -$338M | $125M | -$115M | $81M | |
Ending Cash (CF) | $58M | $121M | $529M | $334M | $429M | |
Levered Free Cash Flow | $692M | $238M | $620M | $248M | $440M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $644M | $417M | $1.4B | $1.3B | $1.2B | |
Depreciation & Amoritzation | $665M | $830M | $994M | $1B | $1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.4B | $1.5B | $2.8B | $2.4B | $2.7B | |
Capital Expenditures | $590M | $340M | $560M | $630M | $668M | |
Cash Acquisitions | -$351M | -$94M | -$164M | -$548M | -$782M | |
Cash From Investing | -$591M | $413M | -$287M | -$1.1B | -$1.4B | |
Dividends Paid (Ex Special Dividend) | -$135M | -$140M | -$179M | -$220M | -$263M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1B | -- | -$382M | $540M | $1.6B | |
Long-Term Debt Repaid | -$1.3B | -$1.1B | -$400M | -$700M | -- | |
Repurchase of Common Stock | -$53M | -$200M | -- | -- | -- | |
Other Financing Activities | -$592M | -$845M | -$1.1B | -$1.1B | -$1.4B | |
Cash From Financing | -$925M | -$1.9B | -$2.1B | -$1.5B | -$1.2B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$106M | $65M | $414M | -$191M | $103M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $820M | $1.2B | $2.2B | $1.8B | $2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $392M | $209M | $443M | $336M | $492M | |
Depreciation & Amoritzation | $178M | $231M | $257M | $254M | $262M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $789M | $339M | $742M | $418M | $638M | |
Capital Expenditures | $97M | $101M | $122M | $170M | $198M | |
Cash Acquisitions | -$35M | -$3M | -$4M | -$94M | -$624M | |
Cash From Investing | -$108M | -$81M | $158M | -$261M | -$819M | |
Dividends Paid (Ex Special Dividend) | -$35M | -$35M | -$52M | -$63M | -$75M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $382M | -- | $107M | $1.1B | |
Long-Term Debt Repaid | -$576M | -$750M | -$400M | -- | -- | |
Repurchase of Common Stock | -$3M | -$25M | -- | -- | -$333M | |
Other Financing Activities | -$72M | -$168M | -$323M | -$316M | -$399M | |
Cash From Financing | -$686M | -$596M | -$775M | -$272M | $262M | |
Beginning Cash (CF) | $63M | $456M | $404M | $453M | $349M | |
Foreign Exchange Rate Adjustment | -- | $3M | -- | -$4M | -$1M | |
Additions / Reductions | -$5M | -$338M | $125M | -$115M | $81M | |
Ending Cash (CF) | $58M | $121M | $529M | $334M | $429M | |
Levered Free Cash Flow | $692M | $238M | $620M | $248M | $440M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.